News

Small caps round-up: IMS Maxims, William Sinclair, Galleon

08 May 2007 16:38:00

Shares in IMS Maxims surged ahead after the healthcare software provider said it has seen continued growth, helped by its NHS contract.

Revenue and pre-tax profit for the year ending 31 March 2007 has increased due to the contract to supply IMS clinical applications at Barking, Havering and Redbridge NHS Trust.

"The group expects to report a continued growth in operating profits before interest, taxation and minority interests when the full year results are released in September 2007," it said.

Branded garden products provider William Sinclair was also up after saying it experienced strong demand from its retail section due to good weather.

"As a result of strong sales conditions though the Easter period and of continued management action to reduce exposure to low margin business and to focus on increasing higher margin sales activity, the company also expects to materially exceed current market expectations for its full year profitability," the group said.

William Sinclair added that its on-going restructuring and recovery strategy has focused on margin improvement and customer service to improve profitability.

Intellectual property group Galleon said it has received re-orders from PepsiCo for its patent toy IP Blasterz, amounting to about €300,000.

"The substantial sales uplift that Blasterz is delivering to our clients has already resulted in a re-order, which indicates that once we have rolled this product out globally we can expect to see long term sustainable revenues from this product as territories reuse the IP for other promotions," commented chief executive Stephen Green.

Galleon received its first order for Blasterz in early 2006 and has since received orders totalling €4.3m.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.